Kyntra Bio, Inc.: Form 8-K, filed Oct 3, 2024
Filed with the SEC on Oct 3, 2024 and accepted by EDGAR at Oct 3, 2024, 20:05 ET.
Items reported
- Item 1.02 Termination of a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-24-112331. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.